KFAR SABA, ISRAEL – Feb 3, 2016 – Colospan Ltd., a company developing revolutionary solutions for colorectal surgery, announced that AMIT (The Alfred Mann Institute at the Technion) has invested $0.5M in the company.
AMIT is the Technion acceleration hub which supports the development and commercialization of exceptional biomedical innovations conceived by Technion students, faculty and alumni. Established in 2006 by Dr. Alfred E. Mann, an American entrepreneur and philanthropist, and by the Technion – Israel Institute of Technology, AMIT aspires to bridge the gap between applied academic research and commercial success. The Technion – Israel Institute of Technology is renowned for its world class research and its unique entrepreneurial spirit of researchers, students and alumni.
“Having AMIT invest in our technology is yet another mark of distinction,” said Boaz Assaf, CEO, Colospan Ltd. “AMIT is a prestigious and reputable entity, with a history of innovation and entrepreneurship. We are proud to be associated with them and enthusiastic about having their support.”
Colospan Ltd. is a clinical stage medical device company active since December 2010. Colospan Ltd focuses on developing novel proprietary technology for colorectal surgery. The company is dedicated to meeting the first and foremost challenge in colorectal surgery by addressing the profound clinical and economic pains associated with anastomotic leaks. Colospan Ltd focuses on developing a safe, effective alternative for the ostomy pouch, to improve medical procedures, reduce health risks and upgrade patients’ wellbeing.
Bringing together clinical, technical and marketing expertise since its inception, Colospan’s competitive advantage stems from the synergy between these domains. Its team consists of seasoned professionals in marketing, sales and development of surgical devices colorectal surgery. It also boasts a distinguished scientific advisory team comprising KOL physicians from Europe and the United States specializing in the colorectal surgery